Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ria Kundu"'
Autor:
Aida Rezaie, Ria Kundu, Kayvon Sotoudeh, Brett Hughes, Hadiatou Barry, Indu Srinivasan, Keng-Yu Chuang
Publikováno v:
American Journal of Gastroenterology. 117:e2312-e2313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8aa4e276b4a93b445d9b0e01dcd3579
https://doi.org/10.14309/01.ajg.0000871388.29666.2f
https://doi.org/10.14309/01.ajg.0000871388.29666.2f
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:451-457
Despite the improvement in overall survival in patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era, the occurrence of central nervous system (CNS) relapse heralds a very poor prognosis. The evidence is conflicting on the incidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d30470613c160c628a736c5340e634f5
https://doi.org/10.1016/j.clml.2015.02.026
https://doi.org/10.1016/j.clml.2015.02.026
Publikováno v:
Cancer Research. 75:P5-15
Introduction Breast cancer is the most common female cancer in the United States. Median survival for patients with metastatic disease is 18 to 24 months with some patients enjoying long term survival1,2. Multiple studies have documented that cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4004713f63fc024b011a25fb80945bb
https://doi.org/10.1158/1538-7445.sabcs14-p5-15-15
https://doi.org/10.1158/1538-7445.sabcs14-p5-15-15
Publikováno v:
Journal of Cancer Prevention & Current Research. 5
The outcome of patients with Diffuse Large B Cell Lymphoma (DLBCL) has significantly improved in the rituximab era. But CNS relapse remains a major complication with very poor prognosis. Systemic chemotherapy with prophylactic CNS directed therapy ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::728fa51ed7a5d1cfe443e7bd08e182e6
https://doi.org/10.15406/jcpcr.2016.05.00177
https://doi.org/10.15406/jcpcr.2016.05.00177
Publikováno v:
Nutrition and cancer. 67(2)
Breast cancer, the most common female malignancy in the world, has a strong association with obesity and insulin resistance. The importance of these risk factors goes up significantly in patients already affected by this cancer as they negatively aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6ed1ddd31b52586bd44812d3620682
https://pubmed.ncbi.nlm.nih.gov/25625592
https://pubmed.ncbi.nlm.nih.gov/25625592
Publikováno v:
American journal of clinical oncology. 40(3)
Central nervous system (CNS) hemangiopericytomas are rare mesenchymal tumors of the brain. In the absence of randomized clinical trials or large studies, the only information we have about the natural history and the management is from isolated clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa7b296362398e988e8ac730e7d48d01
https://pubmed.ncbi.nlm.nih.gov/25350465
https://pubmed.ncbi.nlm.nih.gov/25350465
Publikováno v:
Kardiologia polska. 71(10)
We describe the management of a young patient who had experienced a cocaine overdose. The patient presented with altered mental status and seizures and subsequently developed a wide complex arrhythmia with a rare alternating bundle branch block patte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372854d28ed7a199f3568bf6e9e57964
https://pubmed.ncbi.nlm.nih.gov/24197589
https://pubmed.ncbi.nlm.nih.gov/24197589
Publikováno v:
American journal of therapeutics. 20(6)
Idiopathic thrombocytopenic purpura (ITP) is characterized by premature platelet destruction in the reticuloendothelial system due to the presence of autoantibodies against the platelet membrane proteins. Patients who are resistant to the traditional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685835d479daf0c6d623dd75432d5b57
https://pubmed.ncbi.nlm.nih.gov/21822117
https://pubmed.ncbi.nlm.nih.gov/21822117
Publikováno v:
Blood. 124:1644-1644
INTRODUCTION CNS relapse in DLBCL carries poor prognosis. Some studies have suggested decreased incidence with rituximab, but there are several others reporting otherwise. We analyzed prospective studies in literature to understand the role of rituxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21f88cac6529b0307aa9b9c57ad60f4e
https://doi.org/10.1182/blood.v124.21.1644.1644
https://doi.org/10.1182/blood.v124.21.1644.1644